Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

sunpharma

Sun Pharma agree deal to distribute AstraZeneca type-2 diabetes drug in India

March 24, 2016
Sales and Marketing AstraZeneca, India, Sun Pharma, diabetes, oxra, type 2, type-2

Sun Pharma has agreed a deal with AstraZeneca to promote and distribute their type-2 diabetes drug, dapagliflozin, in India. Marketed …

News
brilinta

AstraZeneca’s Brilinta fails to best aspirin in treating stroke patients

March 23, 2016
Research and Development AstraZeneca, Brilinta, stroke

AstraZeneca has announced top-line results from the Phase III SOCRATES trial, confirming that twice-daily doses of its drug Brilinta (ticagrelor) failed …

News
orexo_logo

AstraZeneca buys rights to Orexo respiratory programme

March 21, 2016
Sales and Marketing AstraZeneca, COPD, asthma, orexo

AstraZeneca has bought the rights to a respiratory programme from Sweden’s Orexo for $5 million. The deal centres on the …

News
medimmune_logo_on_building

AZ drug gets orphan status for rare inflammatory disease

March 9, 2016
Research and Development AstraZeneca, MEDI-551, MedImmune, orphan drug

AstraZeneca’s biologics R&D arm MedImmune has been granted Orphan Drug Designation by the FDA for its investigational anti-CD19 monoclonal antibody, …

News
astrazeneca_plaque

AstraZeneca’s Faslodex gets US FDA nod in combination treatment for breast cancer

March 8, 2016
Manufacturing and Production, Research and Development AstraZeneca, Faslodex, US FDA, palbociclib

UK drug-maker AstraZeneca said the US Food and Drug Administration (FDA) has approved a new indication expanding the use of …

News
drugs_generic

Delivering successful new drugs

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, patents, pharma

Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …

Feature

AstraZeneca licenses European rights to constipation drug for $70m

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, EU, Japan, Luke Miles, ProStrakan Group, constipation drug, moventig

AstraZeneca said on Tuesday it has agreed to licence rights to its constipation drug Moventig to Japan’s ProStrakan Group for …

News
astrazeneca_plaque

AstraZeneca announces tremelimumab setback in mesothelioma test

March 1, 2016
Manufacturing and Production, Research and Development AstraZeneca, Cancer, MedImmune, tremelimumab

AstraZeneca and its global biologics research and development arm, MedImmune, have announced a setback in the result of their Phase …

News
ema_logo

EMA recommends AZ/Acerta drug for orphan status in three indications

February 25, 2016
Research and Development AstraZeneca, EMA, Orphan Drugs

The European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has recommended AstraZeneca and Acerta’s acalabrutinib (ACP-196) for designation …

News
az_logo_on_building

AZ’s durvalumab awarded breakthrough status in bladder cancer

February 18, 2016
Research and Development AstraZeneca, FDA, bladder cancer

AstraZeneca, and its biologics/R&D arm MedImmune, have won FDA Breakthrough Therapy status for their bladder cancer drug durvalumab (MEDI4736), which …

News
astrazeneca_plaque

AZ warns of patent losses as revenues fall

February 4, 2016
Medical Communications, Sales and Marketing AstraZeneca, Crestor, Zurampic

AstraZeneca announced full-year revenues down 7% to $24.7 billion, and Q4 sales down 5% to $6.4 billion, as the London-based …

News
AZ sign

AstraZeneca’s Tagrisso gets EU lung cancer sign-off

February 4, 2016
Sales and Marketing AstraZeneca, European Commission, NSCLC, Tagrisso, non-small cell lung cancer, osimertinib

The European Commission (EC) has granted conditional marketing authorisation to AstraZeneca’s Tagrisso to treat locally advanced or metastatic non-small cell …

News
Lynparza

AZ’s Lynparza gets prostate cancer breakthrough status

January 28, 2016
Sales and Marketing AstraZeneca, Breakthrough Therapy Designation, FDA, lynparza, olaparib, prostate cancer

AstraZeneca’s Lynparza has been granted breakthrough therapy designation by the FDA as a monotherapy for the treatment of a specific …

News
Researcher

Big pharma and UK universities launch £40m innovation fund

January 25, 2016
Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …

News
a

AstraZeneca and MedImmune in oncology research deals

January 12, 2016
Manufacturing and Production, Research and Development AstraZeneca, Incyte, MedImmune, Moderna Therapeutics

AstraZeneca and its biologics arm MedImmune are launching new agreements with partner companies, to develop new targets for cancer, and …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026